Advanced search
Publication Cover
Journal of Medical Economics Volume 27, 2024 - Issue 1
Submit an article Journal homepage
847
Views
0
CrossRef citations to date
0
Altmetric
Oncology

Integrated budget impact model to estimate the impact of introducing selpercatinib as a tumor-agnostic treatment option for patients with RET-altered solid tumors in the US

Naleen Raj Bhandaria Eli Lilly and Company, Indianapolis, IN, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4452-8021
ORCID Icon,
Adrienne M. Gilligana Eli Lilly and Company, Indianapolis, IN, USA
,
Julie Myersb Medical Decision Modeling Inc, Indianapolis, IN, USA
,
Amine Ale-Alia Eli Lilly and Company, Indianapolis, IN, USA
&
Lee Smolenb Medical Decision Modeling Inc, Indianapolis, IN, USAORCID Iconhttps://orcid.org/0000-0002-9931-8945
ORCID Icon
Pages 348-358 | Received 31 Oct 2023, Accepted 07 Feb 2024, Published online: 06 Mar 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.